KalVista Pharmaceuticals, Inc. ($KALV)
Piekos Brian โ Chief Financial Officer
Shares
1,767
Price
$15.57
Total Value
$27,506.54
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Piekos Brian |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 23, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 25, 2026 |
| Shares Sold | 1,767 |
| Price per Share | $15.57 |
| Total Value | $27,506.54 |
| Shares Owned After | 13,762 |
| Derivative | No |
| Accession Number | 0001815308-26-000002 |
| Document | View SEC Filing |